J&J’s D.C. reimbursement office
This article was originally published in The Gray Sheet
Executive Summary
Daniel Waldmann of The Waldmann Group, consultant to St. Jude Medical and the Medical Device Manufacturers Association, becomes Johnson & Johnson director of federal affairs & reimbursement for medical devices June 2, overseeing the Cypher sirolimus-eluting stent and iBOT stair-climbing wheelchair. He joins Health Policy Director Greg White in J&J's Washington, D.C. office...